Citation
de Bruin, J H F M., et al. "[More Hereditary Intestinal Cancer Can Be Detected if Patients With Colorectal Carcinoma That Are Selected By the Pathologist Are Examined for Microsatellite Instability]." Nederlands Tijdschrift Voor Geneeskunde, vol. 149, no. 32, 2005, pp. 1792-8.
de Bruin JH, Kievit W, Ligtenberg MJ, et al. [More hereditary intestinal cancer can be detected if patients with colorectal carcinoma that are selected by the pathologist are examined for microsatellite instability]. Ned Tijdschr Geneeskd. 2005;149(32):1792-8.
de Bruin, J. H., Kievit, W., Ligtenberg, M. J., Nagengast, F. M., Adang, E. M., Ruers, T. J., Kleibeuker, J. H., Sijmons, R. H., van Krieken, J. H., & Hoogerbrugge, N. (2005). [More hereditary intestinal cancer can be detected if patients with colorectal carcinoma that are selected by the pathologist are examined for microsatellite instability]. Nederlands Tijdschrift Voor Geneeskunde, 149(32), 1792-8.
de Bruin JH, et al. [More Hereditary Intestinal Cancer Can Be Detected if Patients With Colorectal Carcinoma That Are Selected By the Pathologist Are Examined for Microsatellite Instability]. Ned Tijdschr Geneeskd. 2005 Aug 6;149(32):1792-8. PubMed PMID: 16121665.
TY - JOUR
T1 - [More hereditary intestinal cancer can be detected if patients with colorectal carcinoma that are selected by the pathologist are examined for microsatellite instability].
AU - de Bruin,J H F M,
AU - Kievit,W,
AU - Ligtenberg,M J L,
AU - Nagengast,F M,
AU - Adang,E M M,
AU - Ruers,T J,
AU - Kleibeuker,J H,
AU - Sijmons,R H,
AU - van Krieken,J H J M,
AU - Hoogerbrugge,N,
PY - 2005/8/27/pubmed
PY - 2005/9/24/medline
PY - 2005/8/27/entrez
SP - 1792
EP - 8
JF - Nederlands tijdschrift voor geneeskunde
JO - Ned Tijdschr Geneeskd
VL - 149
IS - 32
N2 - OBJECTIVE: To determine whether an investigation of microsatellite instability (MSI) in patients with colorectal carcinoma that have been selected by the pathologist could increase the number of detected families with hereditary non-polyposis colorectal carcinoma (HNPCC). DESIGN: Prospective inventory. METHOD: Pathologists selected patients with a newly diagnosed colorectal carcinoma for MSI analysis of their tumour tissue if they met one of the following four criteria: (a) colorectal carcinoma diagnosed below 50 years of age; (b) a second colorectal carcinoma; (c) a combination of colorectal carcinoma and another HNPCC-related cancer; (d) colorectal adenoma with high-grade dysplasia diagnosed below 40 years of age. Patients with a positive MSI-test were referred to a clinical geneticist. The new strategy was introduced and explored in 5 hospitals for a period of to months. RESULTS: The new strategy was adopted and implemented successfully by pathologists and surgeons and accepted with satisfaction by the patients. Of the 55 patients included, 10 had a positive MSI-test. In 8/10 patients, DNA-mutation analysis was started by the clinical geneticist and 3 germline mutations in the MSH2-gene were detected. In 2 of 3 families with a pathogenic mutation, the family history alone did not fulfil the clinical criteria for HNPCC. CONCLUSION: Selection by the pathologist for MSI investigation was feasible in daily practice and identified more HNPCC patients than selection based on family history alone.
SN - 0028-2162
UR - https://www.unboundmedicine.com/medline/citation/16121665/[More_hereditary_intestinal_cancer_can_be_detected_if_patients_with_colorectal_carcinoma_that_are_selected_by_the_pathologist_are_examined_for_microsatellite_instability]_
L2 - https://ClinicalTrials.gov/search/term=16121665 [PUBMED-IDS]
DB - PRIME
DP - Unbound Medicine
ER -